Finding the Sweet Spot? Differential Diabetes Risks in Autologous Breast Reconstruction

Area of Science:

• Plastic Surgery
• Oncology
• Endocrinology

Background:

• Autologous breast reconstruction (ABR) offers improved quality of life but carries risks.
• Diabetes mellitus is a known risk factor for postoperative morbidity.
• Existing research often overlooks differences between diabetes managed with oral agents (DM-ORAL) and insulin (DM-INS).

Purpose of the Study:

• To compare perioperative complication rates in breast cancer patients undergoing ABR.
• To differentiate risks associated with DM-ORAL versus DM-INS.
• To inform treatment-specific risk stratification for ABR.

Main Methods:

• Analysis of the National Surgical Quality Improvement Program database (2008-2021).
• Inclusion of female breast cancer patients undergoing immediate ABR.
• Categorization of diabetes status: nondiabetic, DM-ORAL, and DM-INS.

Main Results:

• Diabetes prevalence increased over time, driven by DM-ORAL.
• Diabetics had higher overall, medical, and surgical complication rates than nondiabetics.
• DM-INS patients showed higher rates of unplanned readmission and superficial infection compared to DM-ORAL patients.

Conclusions:

• Diabetes is a significant, heterogeneous risk factor in ABR.
• Insulin-treated patients face substantially elevated perioperative risks.
• Risk stratification should consider specific diabetes management strategies.